Biochanin A reduces pancreatic cancer survival and progression.

Bhardwaj, Vikas; Tadinada, Satya Murthy; Jain, Aditi; Sehdev, Vikas; Daniels, Christopher K; Lai, James C K; Bhushan, Alok

Bhardwaj, Vikas; Tadinada, Satya Murthy; Jain, Aditi; Sehdev, Vikas; Daniels, Christopher K; Lai, James C K; Bhushan, Alok.

Affiliation

Bhardwaj V; aDepartment of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee bDepartment of Biological Sciences, University of Iowa, Iowa City, Iowa cDepartment of Molecular and Biomedical Pharmacology, University of Kentucky, Lexington, Kentucky dDepartment of Pharmaceutical Sciences, Long Island University, Brookville, New York eDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, Idaho fDepartment of Pharmaceutical Sciences, Jeffe

Anticancer Drugs ; 25(3): 296-302, 2014 Mar.

Article in En | MEDLINE | ID: mdl-24201306

Subject(s)

Antineoplastic Agents/pharmacology; Cell Proliferation/drug effects; Cell Survival/drug effects; Genistein/pharmacology; Pancreatic Neoplasms/pathology; Apoptosis/drug effects; Cell Line, Tumor/drug effects; Humans; Neoplasm Invasiveness; Signal Transduction

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Cell Survival / Genistein / Cell Proliferation / Antineoplastic Agents Limits: Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google